The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to compare two surgical techniques (high vacuum and low vacuum) on corneal endothelium after phacoemulsification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2007
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2006
CompletedFirst Posted
Study publicly available on registry
September 1, 2006
CompletedStudy Start
First participant enrolled
March 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedDecember 25, 2009
October 1, 2008
5 months
August 31, 2006
December 24, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total ultrasound energy dissipated to the eye, total infused fluid, Endothelial cell loss
All patients were examined on postoperative day 1 and weeks 1, 6 and 12.
Study Arms (2)
High vacuum group
ACTIVE COMPARATORThose patients who underwent phacoemulsification using high hydrodynamic parameter: 400 mmHg vacuum and 40 ml/min flow rate.
Low vacuum group
ACTIVE COMPARATORPatients who underwent phacoemulsification using low hydrodynamic parameters: 200 mmHg vacuum and 20 ml/min flow rate.
Interventions
All surgeries were performed using Sovereign phacoemulsification system (AMO) using Whitestar technology.
Eligibility Criteria
You may qualify if:
- Moderate lens opacity (Nuclear sclerosis 3+)
- Age between 50 to 70 years
You may not qualify if:
- Previous corneal pathology (dystrophic or degenerative such as Fuchs' endothelial dystrophy or advanced trachoma),
- Pseudoexfoliation syndrome (PEX),
- History of intra ocular surgery,
- Glaucoma or ocular hypertension,
- Eyes with a history of anterior uveitis,
- Diabetes mellitus,
- Anterior chamber depth (ACD) less than 2.5 mm or more than 4 mm,
- Axial length less than 21 mm or more than 25 mm,
- Density of endothelial cells less than 1500 cells per mm2,
- Polymegatism (CV \> 0.4),
- Keratometric astigmatism more than 1.5 Diopters (D),
- History of contact lens usage,
- Intra-operative complications (posterior capsule rupture with or without vitreous loss),
- Postoperative uveitis,
- Postoperative surgical wound leakage,
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alireza Baradaran Raffiee
Tehran, Tehran Province, 16666, Iran
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alireza Baradaran Raffiee, MD
Ophthalmic Research Center of Shaheed Beheshti Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 31, 2006
First Posted
September 1, 2006
Study Start
March 1, 2007
Primary Completion
August 1, 2007
Study Completion
December 1, 2007
Last Updated
December 25, 2009
Record last verified: 2008-10